Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Bunse, Mario Dr. (3) Chen, Wei Prof. Dr. (1) Edes, Inan Dr. (2) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (2) Kammertöns, Thomas Dr. (4) Kettenmann, Helmut Prof. Dr. (1) Kieback, Elisa Dr. (2) Ku, Min-Chi Dr. (1) Lorenz, Felix Dr. (2) Niendorf, Thoralf Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (21) Waiczies, Helmar Dr. (1) Waiczies, Sonia Dr. (1) Wolf, Susanne Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (5) (-) Leisegang, Matthias Dr. (8) 1998 (2) (-) 2000 (2) 2003 (4) 2004 (1) 2005 (3) 2006 (2) 2007 (1) 2008 (2) 2009 (1) 2010 (4) 2011 (2) (-) 2012 (3) 2014 (2) (-) 2015 (3) (-) 2016 (2) 2017 (2) 2018 (1) 2019 (1) 2021 (1) Biology of Malignant Lymphomas (11) Cancer Genetics and Cellular Stress Responses (1) Genetics and Genomics of Cardiovascular Diseases (1) Immune Regulation and Cancer (2) Microenvironmental Regulation in Autoimmunity and Cancer (9) Molecular Cardiovascular Research (1) (-) Molecular Cell Biology and Gene Therapy (10) Molecular Immunology and Gene Therapy (21) Nephrology and Inflammatory Vascular Diseases (1) Signal Transduction in Tumor Cells (3) Structural Biology of Membrane-Associated Processes (1) Systems Biology of Gene Regulatory Elements (1) Translational Tumorimmunology (3) 10 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Leisegang, Matthias Dr.Molecular Cell Biology and Gene Therapy2000201220152016 Sort: Result score Newest to oldest Oldest to newest June 01, 2016 / Clin Cancer Res Eradication of large solid tumors by gene therapy with a T cell receptor targeting a single cancer-specific point mutation M. Leisegang B. Engels K. Schreiber P.Y. Yew K. Kiyotani C. Idel A. Arina J. Duraiswamy R.R. Weichselbaum W. Uckert Y. Nakamura H. Schreiber March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein June 01, 2015 / BIOspektrum Designer T cells - New possibilities for immunotherapy of cancer [Designer-T-Zellen - neue Möglichkeiten für die Immuntherapie von Krebs] M. Leisegang W. Uckert April 01, 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber April 01, 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein October 01, 2012 / J Virol Protective capacity of virus-specific T cell receptor (TCR)-transduced CD8 T cells in vivo K. Mueller A. von Maessenhausen U. Aichele L. Staerck M. Leisegang W. Uckert H. Pircher July 15, 2012 / J Immunol Human antitumor CD8+ T cells producing Th1 polycytokines show superior antigen sensitivity and tumor recognition S. Wilde D. Sommermeyer M. Leisegang B. Frankenberger B. Mosetter W. Uckert D.J. Schendel April 12, 2012 / Blood TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo S. Spranger I. Jeremias S. Wilde M. Leisegang L. Staerck B. Mosetter W. Uckert M.H.M. Heemskerk D.J. Schendel B. Frankenberger January 01, 2000 / Hum Gene Ther Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype W. Uckert C. Becker M. Gladow D. Klein T. Kammertoens L. Pedersen T. Blankenstein January 01, 2000 / J Gene Med MLV-10A1 retrovirus pseudotype efficiently transduces primary human CD4+ T lymphocytes M. Gladow C. Becker T. Blankenstein W. Uckert
June 01, 2016 / Clin Cancer Res Eradication of large solid tumors by gene therapy with a T cell receptor targeting a single cancer-specific point mutation M. Leisegang B. Engels K. Schreiber P.Y. Yew K. Kiyotani C. Idel A. Arina J. Duraiswamy R.R. Weichselbaum W. Uckert Y. Nakamura H. Schreiber
March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
June 01, 2015 / BIOspektrum Designer T cells - New possibilities for immunotherapy of cancer [Designer-T-Zellen - neue Möglichkeiten für die Immuntherapie von Krebs] M. Leisegang W. Uckert
April 01, 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
April 01, 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
October 01, 2012 / J Virol Protective capacity of virus-specific T cell receptor (TCR)-transduced CD8 T cells in vivo K. Mueller A. von Maessenhausen U. Aichele L. Staerck M. Leisegang W. Uckert H. Pircher
July 15, 2012 / J Immunol Human antitumor CD8+ T cells producing Th1 polycytokines show superior antigen sensitivity and tumor recognition S. Wilde D. Sommermeyer M. Leisegang B. Frankenberger B. Mosetter W. Uckert D.J. Schendel
April 12, 2012 / Blood TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo S. Spranger I. Jeremias S. Wilde M. Leisegang L. Staerck B. Mosetter W. Uckert M.H.M. Heemskerk D.J. Schendel B. Frankenberger
January 01, 2000 / Hum Gene Ther Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype W. Uckert C. Becker M. Gladow D. Klein T. Kammertoens L. Pedersen T. Blankenstein
January 01, 2000 / J Gene Med MLV-10A1 retrovirus pseudotype efficiently transduces primary human CD4+ T lymphocytes M. Gladow C. Becker T. Blankenstein W. Uckert
